>
  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Agnosia Treatment Companies

Agnosia refers to a neurological condition where an individual has difficulty recognizing or interpreting sensory information, such as visual, auditory, or tactile stimuli, despite having intact sensory pathways. The treatment of agnosia often involves rehabilitation strategies, compensatory techniques, and addressing the underlying neurological conditions.

Agnosia Treatment Companies

 


Latest Agnosia Treatment Companies Update:

BrainQ Technologies announced positive results from a Phase 2a trial of their non-invasive brain stimulation therapy for visual agnosia. This technology offers a potential for non-invasive treatment, which could have significant advantages over current medication or surgery. (Jan 12, 2024)


Researchers at the University of California, San Francisco discovered a new genetic mutation associated with a specific type of agnosia, potentially opening doors for targeted therapy development. This finding could lead to more personalized treatment approaches in the future. (Dec 22, 2023)


Several academic institutions are conducting research on using virtual reality (VR) for agnosia rehabilitation. VR environments can provide controlled stimuli and personalized training programs, potentially improving sensory recognition and cognitive function. (Nov 17, 2023) No major pharmaceutical companies have announced large-scale investments or initiatives in the Agnosia Treatment Market yet. However, smaller biotech startups and research institutions are actively exploring potential therapies and technologies.


The National Institute of Neurological Disorders and Stroke (NINDS) continues to fund research on agnosia and related disorders, providing valuable resources for further development. (Jan 23, 2024)


Patient advocacy groups like the American Academy of Neurology and the National Organization for Rare Disorders (NORD) are raising awareness about agnosia and advocating for increased research funding. (Jan 23, 2024)


List of Agnosia Treatment Key companies in the market

  • B. Braun Melsungen (Germany)

  • Pfizer Inc. (U.S.)

  • Lupin ltd. (India)

  • Fujifilm Holdings (Japan)

  • GE Healthcare (U.S.)

  • Siemens Healthcare(U.S.)

  • Philips Healthcare (U.S.)

  • F. Hoffmann-La Roche AG (Switzerland)

  • Aurobindo Pharma Ltd (India)

  • Sandoz GmBH (Austria)

  • Stellar- Bio Labs (India)

  • Fresenius Kabi Ipsum SRL (Italy)

  • Zhuhai United Laboratories Co Ltd (China)

  • Cspc Zhongnuo Pharmaceutical Shijiazhuang Co Ltd (China)

  • IPCA Labs ltd. (India)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.